ACC 20WCC Virtual Conference 2020
Format:33 videos + 104 pdfs, size: 11.2 GB
Course Audience: cardiologist
101 – Coronary Artery Disease – Challenges in 2020 Cardiovascular Update For the Clinican I — A Symposium by Valentin Fuster (Video MP4 Format)
103 – Chronic Coronary and Systemic Disease 2020, Challenges of Management and Prevention Cardiovascular Update For the Clinican II — A Symposium by Valentin Fuster (Video MP4 Format)105 – Cardiac Failure in 2020 Cardiovascular Update for the Clinician III — A Symposium by Valentin Fuster (Video MP4 Format)107 – Electrical Failure in 2020 Cardiovascular Update for the Clinician VI — A Symposium by Valentin Fuster (Video MP4 Format)108 – Structural Heart Disease – Challenges in 2020 Cardiovascular Update for the Clinician V — A Symposium by Valentin Fuster (Video MP4 Format)401. ACC.20 WCC Opening Showcase (Video MP4 Format)402 – Joint American College of Cardiology and Journal of American College of Cardiology Late-Breaking Clinical Trials (Video MP4 Format)403 – Featured Clinical Research I (Video MP4 Format)405 – Joint American College of Cardiology-New England Journal of Medicine Late-Breaking Clinical Trials (Video MP4 Format)406 – Late-Breaking Clinical Trials III (Video MP4 Format)409 – Featured Clinical Research II (Video MP4 Format)410 – Late-Breaking Clinical Trials IV (Video MP4 Format)411 – Joint American College of Cardiology-Journal of the American Medical Association Late-Breaking Clinical Trials (Video MP4 Format)412 – Featured Clinical Research III (Video MP4 Format)416 – Keynotes- Antonio Colombo 2020 Simon Dack Keynote My Lifetime Journey in Coronary Interventions – Part 1 (Video MP4 Format)51 – CardioObstetrics Intensive I Featuring the 51st Annual Louis F. Bishop Keynote Decreasing Maternal Cardiovascular Mortality Today, Tomorrow and in the Future (Video MP4 Format)52 – CardioObstetrics Intensive II Decreasing Maternal Cardiovascular Mortality Today, Tomorrow and in the Future (Video MP4 Format)608-01-PujaMehta-Persistent Angina When to Suspect INOCA (PDF Format)608-02-JamiesonBourque-Noninvasive Diagnosis of INOCA What Are My Tools (PDF Format)608-03-ChristopherSchumann-Case 1 Diagnosis of a Patient Using Noninvasive Methods (PDF Format)608-05-NissiSuppogu-Case 2 Diagnosis of a Patient Using Invasive Methods (PDF Format)608-06-C.NoelBaireyMerz-Optimal Medical Therapy The WARRIOR Trial (PDF Format)626-02-PaulWang-How Will Wearable Technologies Be Integrated Into Cardiovascular Care of The Near Future (PDF Format)626-03-EugeneChung-2 Case Presentations Featuring Clinical Decision Making With Wearable Data. ARS Polling Will Be Used (PDF Format)627-02-CandaceMorton-Ambulatory Monitoring in The Assessment of Prognosis (PDF Format)627-03-DanielCooper-Predicting Ablation Outcomes With Cardiac MRI And Echocardiography (PDF Format)627-04-AndrewEpstein-Is Catheter Ablation Superior to Antiarrhythmic Drugs in Treating PVCs (PDF Format)630-04-ScottSolomon-Before And After PARAGON Medical Therapy For HFpEF (PDF Format)632-04-SamuelBernard-Cases Presentation Multimodality Approach to Cardiomyopathy Assessment (PDF Format)634-01-JonathonLeipsic-TAVR Challenges Imaging And Measuring Bicuspid Aortic Valves (PDF Format)634-02-RajMakkar-Case Presentation Avoiding Coronary Obstruction in TAVR (PDF Format)634-03-TobyRogers-Case Presentation Leaflet Thickening And Thrombosis – Imaging And Clinical Implications (PDF Format)634-04-DannyDvir-New Paradigms in Valve-in-Valve Planning And Implantation (PDF Format)634-05-HasanJilaihawi-Post-TAVR Leaflet Thrombosis When, Where, And How (PDF Format)634-06-CameronDowling-Computational Modeling of TAVR Fad or Must Have (PDF Format)637-01-DavidWood-What CVD Prevention Services Should Be Covered For Patients in Universal Health Coverage (PDF Format)640-01-JavidMoslehi-Intersections of Cancer And Vascular Disease Biology (PDF Format)640-02-PeterLibby-Clonal Hematopoiesis of Indeterminate Potential CHIP A New LInk Between Cancer And Cardiovascular Disease (PDF Format)640-03-JoshuaBeckman-Global Perspective Managing HIV Associated Cancer And Vascular Complications (PDF Format)640-04-LavanyaKondapalli-Vascular Complications of Immunotherapy in Cancer (PDF Format)640-05-AlexanderBlood-Case Presentation Case 1 A Patient on Immune Checkpoint Inhibitor Therapy Who Develops Vasculitis (PDF Format)640-06-AnjuNohria-Vascular Complications of Targeted Therapies (PDF Format)640-07-AaronAday-Case Presentation Case 2 A Patient on a VEGF Inihibtor With Refractory Hypertension (PDF Format)640-08-JoeLau-Case Presentation Case 3 – A Patient on a TKI (Niolotinib) With Acute Limb Ischemia (PDF Format)640-09-CeciliaLowWang-Managing Risk in Survivors on Androgen Deprivation (PDF Format)640-10-AlecSchmaier-Case Presentation Case 4 – A Patient on Androgen Deprivation With Diabetes And PAD (PDF Format)665-02-MarcSabatine-Genes And Randomization, Two Gifts From God. How Can Genomics Guide Clinical Trials in Cardiology (PDF Format)665-03-JoshuaKnowles-The Future Is Now What Is The Role of Genetic Testing For Monogenic Cardiac Diseases in Preventive Cardiology Today (PDF Format)665-04-ErinBohula-Hot Stuff How Can Measurement of Inflammation Guide Precision in Todays Prevention Practice (PDF Format)665-05-Sotirios-Tsimikas-Not so Little Anymore How Lipoprotein-a Is Emerging to The Forefront of Precision Prevention (PDF Format)678-01-MagdiYacoub-ACC-Talk Five Decades of Pulmonary Hypertension Experience Across The Globe (PDF Format)678-03-Priscilla-Hsue-Update on Infectious Pulmonary Arterial Hypertension Schistosomiasis to HIV (PDF Format)678-05-LieslZuhlke-Current Day Pulmonary Hypertension From Rheumatic Heart Disease Characteristics, Gaps, and Complications (PDF Format)684-03-RaviHira-Case of a Patient With Diabetes And Severe Triple Vessel Disease (PDF Format)684-04-SyedRab-Stenting For Left Main Disease An EXCELlent Way to Go (PDF Format)684-05-MichaelMack-CABG Is The NOBLE Approach to Revascularization in Left Main Disease (PDF Format)684-06-StephenWilkinson-Case of a Patient With Severe Left Main Disease (PDF Format)686-01-MerylCohen-The Impact And Prevention of Obesity in Children With Congenital Heart Disease (PDF Format)686-02-NicoleDempster-Psychological Impact of Exercise Restrictions (PDF Format)686-03-RachelCordina-Exercise in The Fontan Patient The Other Medication (PDF Format)686-04-AliciaWilmoth-Exercise And Fontan My Experience (PDF Format)690-03-PhilippePibarot-Paradoxical Low Flow Low Gradient Severe AS Understanding The Conundrum (PDF Format)690-05-HasanJilaihawi-My Most Challenging Cases CT Planning For TAVR (PDF Format)690-08-JonathonLeipsic-Imaging Post TAVR Valve Implantation The Challenge of Leaflet Thickening (PDF Format)692-06-SahilParikh-How Do I Choose My Stents For Infra-Inguinal Intervention From Eluvia to Supera (PDF Format)696-02-BradleyMaron-Back to Basics Normal Pulmonary Hemodynamics Pressure-Flow Relationship Where Next in Pulmonary Hypertension (PDF Format)696-03-GregoryLewis-Conventional vs. Invasive Cardiopulmonary Exercise Testing Who Gets What, And Why (PDF Format)696-04-MarcoGuazzi-Exercise Induced Pulmonary Hypertension Devil in The Mask Exercise Medications or Combination The Perfect Soup to Unmask The Devil (PDF Format)696-05-JenniferHo-Risk Stratification & Management of Exercise Induced Pulmonary Hypertension (PDF Format)699-01-AndrewHarris-Case Presentation Mitral Regurgitation in a Heart Failure Patient. Patient With Dilated Cardiomyopathy, Heart Failure And Secondary MR ( (PDF Format)699-02-JudyHung-Debate Pro Severe Is Severe We Should Use The Same Definition For Primary And Secondary Mitral Regurgitation (PDF Format)699-04-SheilaKlassen-Case Presentation Patient With Dilated Cardiomyopathy, Heart Failure And Secondary MR (Moderate to Severe) Symptoms And Medical Rx. Wha (PDF Format)700-01-HusseinAbuDaya-Case of a Patient With NSTEMI (PDF Format)710-02-AbdullaDamluji-ST-elevation Myocardial Infarction And Cardiogenic Shock Is There Role For Multivessel PCI (PDF Format)710-03-PaulGurbel-Adjunct Pharmacotherapy For Multivessel PCI Is There a Difference From Single Vessel Revascularization (PDF Format)710-04-MortonKern-Physiologic Assessment For Non-Culprit Vessels During Multivessel PCI (PDF Format)710-05-DavidCox-Radiation Management And Radiographic Contrast For Multivessel PCI What Do You Need to Know (PDF Format)710-06-EmmanouilBrilakis-Management of Complications For Multivessel PCI No Free Lunch in Cardiac Catheterization Laboratory (PDF Format)717-02-LauraOlivieri-Mixed Reality And 3D Printing Gimmick or Groundwork For Innovation (PDF Format)717-04-WHWilsonTang-ACC-Talk What Does The Gut Microbiome Have to Do With The Heart (PDF Format)719-03-BiykemBozkurt-Safety And Efficacy of Other Glucose Control Strategies in Patients With Diabetes And Established Heart Failure (PDF Format)719-04-LucianneWest-Practical Do’s And Don’ts at The Intersection of Diabetes And HF (PDF Format)728-01-LarryBaddour-The Life And Times of IE Pathogens (PDF Format)728-03-RituThamman-Case Presentation It Takes a Village The Heart Valve Team Management of IE (PDF Format)728-04-PurviParwani-Case Presentation IE After TAVR A New Dilemma (PDF Format)729-01-AmyKontorovich-Pregnancy Risks in Patients With Marfan’s And Loey’s Dietz Syndrome (PDF Format)729-03-MelindaDavis-Managing Pregnancy in a Patient With Takayasu’s Arteritis (PDF Format)729-04-VictorTapson-Massive PE in a Peri-Partum Woman (PDF Format)729-05-MargoMinissian-SCAD in a Post-Partum Woman (PDF Format)729-06-TsuyoshiKaneko-Preventing Mechanical Valves Thrombosis in Pregnancy Across The Globe (PDF Format)729-07-YudiOctaviono-Management Strategies For Rheumatic Valve Disease in Pregnancy (PDF Format)733-02-MichaelZile-Baroreceptor Stimulation in Heart Failure Still Honing Our Reflexes (PDF Format)738-03-Daniel-Schimmel-BPA in 2020 What’s The Best Approach (PDF Format)741-01-JoshuaBeckman-Debate Microvascular Disease Is an Important Driver of CLI (PDF Format)741-03-ScottKinlay-Debate Paclitaxel Increases Mortality in PAD (PDF Format)741-04-EricSecemsky-Debate Paclitaxel Does Not Increase Mortality in PAD (PDF Format)741-05-SoniaAnand-Debate Rivaroxaban For All Patients With PAD (PDF Format)741-07-ESebastianDebus-Managing CLI Around The Globe How Access Impacts Care Patterns (PDF Format)749-01-AnaBarac-Patient With LV Dysfunction Before And During Cardiotoxic Treatment How to Diagnose, How to Monitor, What to Do Regarding Treatment (PDF Format)749-02-PaaladineshThavendiranathan-StrainGuided Cardioprotection During Cancer Therapy (PDF Format)749-03-NausheenAkhter-Practical Approach to Setting up a Strain Protocol For Oncology Patients (PDF Format)749-04-LuciaFlorio-Cardiac Function in Cancer Survivors Role For CMR (PDF Format)749-05-LaurenBaldassarre-Tissue Characterization and Molecular Imaging for Assessment of Immune Checkpoint Inhibitor Ccardiotoxicity in Oncology Patients (PDF Format)753-01-ChristieBallantyne-Elevated Triglycerides And ASCVD Risk Reduction It Is EPA That Matters (PDF Format)753-03-JenniferRobinson-Statin Associated Muscle Symptoms It Is All in The Head Fake News (PDF Format)753-04-LynneBraun-SAMs Listen to The Patient Don’t Throw Away The Baby With The Bathwater (PDF Format)753-06-SalimVirani-Non-Statin Selection in Secondary ASCVD Prevention Should Be Sequential With Ezetimibe First And Then PCSK9i (PDF Format)753-07-PradeepNatarajan-Genetic Testing in ASCVD Risk Assessment It Is Here, Alive And Healthy (PDF Format)753-08-ErinMichos-Genetic Testing in ASCVD Risk Assessment A Far-Fetched Idea (Stick to The Basics) (PDF Format)758-01-MichaelReardon-1 TAVR vs SAVR Can Precision Medicine Decide (PDF Format)758-02-SergeHarb-2 The Role of 3D Imaging And Printing in The Management of Valve Disease (PDF Format)758-05-EricRoselli-5 Regenerative Heart Valves, How Many Steps From The Future Are We (PDF Format)762-01-AsifJafferani-Case Presentation 1 Bifascicular Block (PDF Format)762-02-RoopinderSandhu-Bifascicular Block And Syncope How to Proceed (PDF Format)762-05-KimGuibone-Case Presentation 3 Autonomic Testing (PDF Format)780-01-Yvesd’Udekem-The Impact of AV Valve Failure in The Fontan (PDF Format)780-02-HaniNajm-From Single V to Two V Using The Subpulmonary LV (PDF Format)780-03-CesarHerrera-State of The Art Imaging Evaluation For Single Right Ventricular Function (PDF Format)780-04-PradeepkumarCharla-Negative Pressure Ventilation as Novel Therapy to Treat Fontan Complications (PDF Format)780-05-RukhmiBhat-Aspirin, Warfarin, NOACs What Should We Use For The Fontan (PDF Format)905 – Highlighted Original Research Global Cardiovascular Health Featuring the WHF Keynote (Video MP4 Format)908 – FIT Forum Stump the Professor (Video MP4 Format)915 – Young Investigator Awards Basic and Translational Science (Video MP4 Format)916 – Young Investigator Awards Clinical Investigations (Video MP4 Format)917 – Young Investigator Awards Outcomes Research (Video MP4 Format)ACC Cardiology Hour at ACC.20-WCC Virtual With Valentin Fuster, MD, PhD, MACC (Video MP4 Format)acc-20-virtual-meeting-disclosure-information-final (PDF Format)ACC.20-WCC Virtual- Day 1 Cardiology Hour (Video MP4 Format)ACC.20-WCC Virtual- Day 2 Cardiology Hour (Video MP4 Format)ACC.20-WCC Virtual- Day 3 Cardiology Hour (Video MP4 Format)Day 1 Highlights – ACC.20-WCC Virtual (Video MP4 Format)Day 1 Overview – ACC.20-WCC Virtual (Video MP4 Format)Day 2 Highlights – ACC.20-WCC Virtual (Video MP4 Format)Day 2 Overview – ACC.20-WCC Virtual (Video MP4 Format)Day 3 Overview – ACC.20-WCC Virtual (Video MP4 Format)E3 – ACC.20-WCC Virtual (Video MP4 Format)TICO – ACC.20-WCC Virtual (Video MP4 Format)